Related by context. All words. (Click for frequent words.) 74 L BLP# 73 Medidur ™ FA 72 Ceflatonin R 72 Ceflatonin ® 70 GW# [003] 70 Glufosfamide 70 Junovan 70 trastuzumab DM1 T DM1 70 YONDELIS 69 Arzerra TM 69 XYOTAX TM 69 GSK '# 69 PF # [002] 69 CRMD# 69 Silodosin 69 PrevOnco 69 Clolar ® 69 Panzem R 69 Qutenza TM 69 Iloperidone 69 Pirfenidone 68 Onco TCS 68 Albugon 68 reslizumab 68 PDX pralatrexate 68 phase IIb clinical 68 PDE4 inhibitor 68 docetaxel Taxotere R 68 Dalbavancin 68 FOLOTYN ® 68 Ridaforolimus 68 BAY #-# 68 oral ridaforolimus 68 Proxinium TM 68 Tezampanel 68 Cloretazine VNP#M 67 Specifid 67 histamine dihydrochloride 67 delivers fluocinolone acetonide FA 67 IL# PE#QQR 67 Fodosine 67 MAGE A3 ASCI 67 Hedgehog Pathway Inhibitor 67 chimeric monoclonal antibody 67 Cloretazine ® 67 mertansine 67 Cloretazine 67 StemEx 67 targeted radiotherapeutic 67 RELOVAIR ™ 67 Velcade bortezomib 67 TLK# 67 TACI Ig 67 MKC# MKC# PP 67 StemEx R 67 Zybrestat 67 Creabilis Therapeutics 66 refractory chronic lymphocytic 66 Vandetanib 66 sorafenib tablets 66 SinuNase ™ 66 gefitinib Iressa 66 Medidur TM FA 66 Ixempra 66 Phase #b/#a clinical 66 OPAXIO TM 66 Phase III Pivotal 66 compound ITMN 66 STEDESA 66 antibody MAb 66 cathepsin K inhibitor 66 Muraglitazar 66 Onconase 66 BRIM2 66 Campath ® 66 tiapamil 66 midstage clinical 66 Personalized Immunotherapy 66 Talabostat 66 Ceflatonin 66 Civacir 66 CVac 66 non nucleoside inhibitor 66 Phase IIb clinical trials 66 Eprodisate KIACTA TM 66 SAFLUTAN 66 Triapine 66 lorvotuzumab mertansine 66 Romiplostim 66 brivaracetam 66 fostamatinib 66 balsalazide tablet 66 acetonide FA 66 CYT# QbG# 66 Xeloda ® 66 Degarelix 66 Xanafide 66 Pertuzumab 66 IgG1 monoclonal antibody 66 Voreloxin 66 Initiates Clinical 66 Amrubicin 66 Troxatyl 66 AVASTIN 66 KNS # 65 Allovectin 7 65 PSMA ADC 65 UPLYSO 65 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 65 Fx #A 65 Luveniq 65 OvaRex ® MAb 65 RhuDex ® 65 seliciclib CYC# 65 Vion Pharmaceuticals 65 Liprotamase 65 BioNumerik 65 fosbretabulin 65 LUCASSIN 65 Temsirolimus 65 ZACTIMA 65 Omnitarg 65 Hycamtin 65 Combidex 65 RhuDex R 65 Onrigin 65 ZEVALIN ® 65 Iluvien ® 65 Exelixis XL# 65 Bayer Onyx 65 ZOLINZA 65 LibiGel ® 65 Solzira ™ 65 Nexavar ® 65 Junovan TM 65 Drug Eluting Stent System 65 SPL# Gel vaginal microbicide 65 2 methoxyestradiol 65 Dasatinib 65 Panzem 65 Iluvien TM 65 HyperAcute 65 NPC 1C 65 volociximab 65 YM Biosciences 65 Anidulafungin 65 depsipeptide 65 GVAX ® 65 BXT # 65 Aflibercept 65 RhuDex 65 ANTEGREN 65 squamous non 65 Mipomersen 65 Medidur FA 65 Anticancer Agent 65 BRILINTA 65 product Fentanyl TAIFUN 65 vinorelbine tartrate 65 Aplidin 65 acyclovir Lauriad R 65 Hsp# Inhibitor 65 anticancer compound 65 metastatic malignant 65 Angiocept 65 PNT# 65 Phase 2a Clinical Trial 65 sunitinib malate 65 histone deacetylase HDAC inhibitor 65 Immunotherapeutic 65 Successfully Completes Phase 65 Phase Ib clinical 65 proteasome inhibitor 65 Pivotal Phase III 65 Arno Therapeutics 65 RhuDex TM 65 treat chronic sinusitis 65 Gemzar ® 65 thalidomide Thalomid 65 Exemestane 65 OPAXIO 65 Telavancin 65 LHRH antagonist 65 docetaxel Taxotere ® 65 tolevamer 65 Davanat 65 TRO# 65 multicenter Phase II 65 Myrexis Inc. 65 cutaneous T 65 Argatroban 65 modulator SERM 65 personalized cellular immunotherapy 65 PrevOnco ™ 65 anti CD3 monoclonal 65 Viralytics 65 HCV protease inhibitor 65 PROVENGE ® 65 Phase 2b Clinical Trial 65 Prospective Randomized 65 Pegloticase 65 TNFerade TM 65 Aryplase 65 terlipressin 65 Mepact 65 mitogen activated ERK kinase 65 Teysuno 64 sargramostim 64 Saxagliptin 64 PI3K/Akt pathway inhibitor 64 PHASE III 64 Pafuramidine 64 radiation sensitizer 64 Bremelanotide 64 OMAPRO ™ 64 NeuroSTAT ® 64 HuLuc# 64 Gamunex C 64 mesylate 64 PANVAC VF 64 SinuNase TM 64 Dyloject TM 64 IMPACT IMmunotherapy 64 telomerase therapeutic 64 Proellex TM 64 Alnara Pharmaceuticals 64 Ocrelizumab 64 Zenpep 64 BEXXAR 64 Daclizumab 64 Initiate Phase 64 octreotide implant 64 EVICEL 64 Panzem R NCD 64 Tarceva TM 64 Kahalalide F 64 Bayer HealthCare Onyx Pharmaceuticals 64 Tesmilifene 64 long acting muscarinic 64 novel therapeutic antibodies 64 naproxen esomeprazole magnesium 64 Tesetaxel 64 Celgene Thalomid 64 Gendux AB 64 peginesatide 64 Boceprevir 64 lapatinib Tykerb 64 TASKi3 64 GLP1 INT TM 64 Zorbtive TM 64 inhaled AAT 64 phase III isavuconazole 64 sublingual tablets 64 metastatic colorectal 64 hormone agonist 64 faropenem 64 Saforis 64 HuMax CD4 64 OvaRex R 64 Crofelemer budesonide foam 64 Calcium Acetate 64 Lubiprostone 64 drug GAP #B# 64 Stimuvax R 64 CD# monoclonal antibody 64 beta 1a 64 Squalamine 64 rhMBL 64 TRANSDUR Bupivacaine 64 Regeneron Pharma 64 Tiuxetan 64 Vitaxin 64 PDUFA Date 64 Liposomal 64 FoldRx Pharmaceuticals Inc. 64 PEG SN# 64 Guanilib 64 histone deacetylase inhibitor 64 Genasense ® 64 ThermoDox ® clinical 64 Pemetrexed 64 Ophthotech 64 Granted Orphan Drug 64 Virulizin R 64 bevacizumab Avastin ® 64 BCIRG 64 Curaxin CBLC# 64 Factor VIIa 64 lexidronam injection 64 Nexavar sorafenib 64 Advexin 64 BCR ABL inhibitor 64 Ziopharm 64 Xcytrin R 64 Tarvacin 64 HuMax EGFr 64 investigational HCV polymerase 64 Marqibo TM 64 HuMax TAC 64 Harbor BioSciences 64 Leukine ® 64 GATTEX ® 64 TNF Tumor Necrosis Factor 64 LEVADEX TM 64 tramiprosate Alzhemed TM 64 randomized controlled Phase 64 TYGACIL 64 Vegenics 64 IMA# 64 Xyrem ® 64 Vernakalant 64 Fujisawa Healthcare Inc. 64 Aplidin R 64 Cetrorelix 64 Bosutinib 64 Zenvia ™ 64 OncoVex 64 ONGLYZA ™ 64 selective adenosine 64 Removab 64 ANYARA 64 liposomal formulation 64 Xelox 64 Hexvix ® 64 WX UK1 64 Insegia 64 Ecallantide 64 ASONEP 64 Catena ® 64 pain palliation 64 Archexin 64 Peginterferon alfa 2b 64 Bafetinib 64 kidney urologic 64 AVAX 64 Anti Tumor 64 oral antiviral 64 Locteron ® 64 plus DOXIL 64 Elotuzumab 64 Eculizumab 64 IV Busulfex 64 intranasal formulation 63 MacroMed 63 Virulizin 63 Conatus Pharmaceuticals 63 FDA APPROVES 63 cetuximab Erbitux R 63 TYZEKA 63 HCV RNA polymerase 63 Zolinza 63 Epratuzumab 63 HDAC Inhibitor 63 Cardio Vascu Grow 63 Initiates Phase 2b 63 Phase Ib Clinical Trial 63 novel oral anticoagulant 63 Accentia Biopharmaceuticals 63 miconazole Lauriad R 63 pralatrexate injection folate analogue 63 phase IIIb 63 Myocet 63 Epiphany Biosciences 63 Parathyroid Hormone 63 SIR Spheres 63 LEUKINE 63 Fibrin Pad 63 Sapacitabine 63 Vectibix panitumumab 63 Afinitor everolimus 63 VivaGel ™ 63 Voraxaze 63 REG1 Anticoagulation System 63 InNexus Biotechnology 63 Ore Pharmaceuticals 63 ONCONASE R 63 Phase 2b Trial 63 Debiopharm SA 63 Alligator Bioscience AB 63 myelodysplastic myeloproliferative diseases 63 Olaparib 63 AEG# 63 Anturol TM 63 BENLYSTA ® 63 gastrointestinal stromal tumors GIST 63 selective androgen receptor modulators 63 Cellegesic 63 Pivotal Phase II 63 SYCREST 63 novel prodrug 63 YONDELIS R 63 WILEX 63 Oral Insulin 63 Prestara TM 63 miconazole Lauriad ® 63 dasatinib Sprycel ® 63 Ramoplanin 63 Bendamustine 63 Litx 63 TRANSDUR ™ 63 Elagolix 63 Tanespimycin 63 Ambrisentan 63 BRIM3 63 metastatic castrate resistant 63 Sprycel dasatinib 63 Oasmia 63 Files IND 63 Orphan Therapeutics 63 RECOTHROM R 63 EndoTAG 63 GeneICE 63 Meets Primary Endpoint 63 CoFactor 63 ORE# 63 ara C 63 PhG alpha 1 63 CombinatoRx Incorporated 63 proteasome inhibitor bortezomib 63 PSN# [001] 63 MOVIPREP R 63 Dacogen injection 63 dextromethorphan quinidine 63 Sirion Therapeutics 63 Deforolimus 63 IMC #B 63 Prolongs Survival 63 Xcellerated T Cells 63 vapreotide acetate 63 Zarnestra 63 CINTREDEKIN BESUDOTOX 63 Elvitegravir 63 Raptiva R 63 BAL# [002] 63 Plicera 63 Hybridon 63 JZP 63 FoldRx 63 Lung Rx 63 EOquin TM 63 sorafenib Nexavar 63 highly selective inhibitor 63 Ixabepilone 63 Polymer Microspheres 63 GSK# [001] 63 CDP# 63 JAK inhibitor 63 Patient Enrolment 63 Prostate AdenoCarcinoma Treatment 63 Proteo 63 Completes Patient Enrollment 63 Adventrx 63 zanolimumab 63 Phase IIb Clinical Trial 63 Chemokine Therapeutics 63 ELACYT 63 oral prodrug 63 VEGF Trap 63 Celgene Revlimid 63 CAMPATH 63 etanercept Enbrel 63 TASKi2 63 IV APAP 63 erlotinib Tarceva ® 63 BUPHENYL R 63 lucinactant 63 ospemifene 63 Initiates Enrollment 63 MKC# MT 63 GRNVAC1 63 Faropenem 63 Aurexis 63 AAG geldanamycin analog 63 selective A2A adenosine receptor 63 Sanvar 63 Vidaza R 63 oncolytic virus therapies 63 Angiotensin Converting Enzyme 63 targeted antifolate 63 Teva Provides Update 63 Gentamicin Surgical Implant 63 epigenetic therapies 63 Inhalation Aerosol 63 Canvaxin 63 Oncolytics Biotech 63 alvimopan 63 THR beta agonist 63 Zalbin 63 Bortezomib 63 investigational immunotherapy 63 Etravirine 63 intravesical infusion therapy 63 Fast Track Status 63 Indaflex TM 63 CR# vcMMAE 63 Avila Therapeutics 63 HepaGam B 63 RAV# 63 Kamada AAT 63 apricitabine ATC 63 TRISENOX ® 63 Motavizumab 63 TELCYTA 63 HepaSphere 63 Commences Phase 63 MyVax 63 Metabasis Therapeutics 63 Dacogen TM 63 Safinamide 63 Afatinib 63 trastuzumab Herceptin R 63 SPRYCEL ® 63 FDA Approvable Letter 63 vernakalant hydrochloride 63 Bazedoxifene 63 Nitec 63 Vinorelbine 63 Tasigna nilotinib 63 ProLindac TM 63 malignant ascites 63 INSPIRE Trial Phase III 63 Xinlay 63 Phase Ib II 63 Omapro 63 ongoing Phase 1b 63 Exherin TM 63 inhalation aerosol 63 Alfacell proprietary ribonuclease 63 Eloxatin ® 63 Omacetaxine 63 Pivotal Phase 63 Azedra 63 Initiates Phase II 63 LUMINATE 63 Homspera TM 63 DOS# 63 Combination REOLYSIN R 63 Annamycin 63 Nuvion 63 Chemokine 63 CEQ# 63 Cloretazine R VNP#M 62 recombinant thrombin 62 GeneMax 62 APEX PD 62 Intravenous Human 62 Prestara 62 Pazopanib 62 GSK# [002] 62 OPi 62 Phase Ib study 62 Alferon N 62 Trastuzumab DM1 62 thymalfasin 62 First Patient Dosed 62 RxKinetix 62 Sanvar R 62 Initiates Phase III 62 Bexion 62 Fibrillex TM 62 Addrenex Pharmaceuticals 62 Zirgan 62 GLP toxicology studies 62 Aviptadil 62 GATTEX TM 62 OTCBB PYTO 62 molecular imaging radiopharmaceutical 62 Phase Ib IIa 62 BEMA Granisetron 62 Initiates Clinical Trial 62 Tibotec BVBA 62 LymphoStat B belimumab 62 Ozarelix 62 Interferon alfa 62 phase IIa clinical 62 Quinamed R 62 Belimumab 62 virus HCV protease inhibitor 62 EnzymeRx 62 EVIZON TM squalamine lactate 62 Alfimeprase 62 Kosan dependence 62 BEMA TM Fentanyl 62 HuMax 62 INCB# [001] 62 Adjuvant Treatment 62 Diabetic Macular Edema DME 62 Phase III Clinical Trial 62 CAELYX 62 Dupuytren Contracture 62 unique alkylating agent 62 valopicitabine NM# 62 Modrenal R 62 essential thrombocythemia ET 62 Yondelis ® 62 JAK2 Inhibitor 62 LAF# 62 UCB Pharma SA 62 Aldara ® 62 bortezomib Velcade R 62 Vicriviroc 62 investigational humanized monoclonal antibody 62 dihydrochloride 62 E1 INT TM 62 granulated mesalamine 62 Gleevec imatinib mesylate 62 oral picoplatin 62 Bezielle 62 confirmatory clinical 62 dasatinib Sprycel 62 Aurograb 62 Vitrasert R 62 ThermoDox R 62 LUX Lung 62 QNEXA 62 Cand5 62 Pyridorin 62 CureDM 62 HCl Tablets 62 intravenous AAT 62 Zosano 62 evaluating satraplatin 62 Keryx Biopharma 62 octreotide acetate 62 Portola Pharmaceuticals 62 novel synthetic peptide 62 Tyrima 62 immunotherapeutic vaccine 62 recurrent glioblastoma multiforme 62 Recombinant Human 62 Activity Assay 62 ofatumumab HuMax CD# 62 Hematide ™ 62 rNAPc2 62 ARRY # 62 Febuxostat 62 Prodarsan R 62 HQK 62 Kuvan sapropterin dihydrochloride 62 Patient Enrollment 62 Phase IIB 62 Generx TM 62 Orapred ODT 62 VitiGam 62 RSR# 62 investigational oral hepatitis C 62 markets HP Acthar 62 Psoriasis Drug 62 incyclinide 62 erlotinib Tarceva 62 SUTENT ® 62 ALVESCO ® 62 Protease Inhibitor 62 DP VPA 62 BrachySil ™ 62 tiuxetan 62 initiated Phase Ib 62 Liprostin 62 novel histone deacetylase 62 Initiate Clinical Trial 62 Copegus ® 62 paclitaxel Taxol ® 62 liver resection surgeries 62 rasagiline tablets 62 ixabepilone 62 candidate deforolimus 62 PhotoPoint R 62 Diamyd R 62 alvespimycin 62 HepeX B 62 tramiprosate ALZHEMED TM 62 Emezine 62 pemetrexed Alimta 62 HuMax HepC TM 62 Prima BioMed 62 diarrhea predominant irritable 62 Uvidem 62 Serdolect ® 62 ALVESCO R 62 ZYBRESTAT TM 62 Vidaza azacitidine 62 Alocrest 62 Eribulin 62 Denufosol 62 ELND-#/AZD-# 62 Hepatocellular Carcinoma HCC 62 CIMYM 62 Ustekinumab 62 Dacogen decitabine 62 Erbitux cetuximab 62 Phase III multicenter 62 Nipent R 62 methylnaltrexone bromide 62 inhibitor RG# 62 investigational antiplatelet agent 62 PEGylated interferon 62 GTC recombinant form 62 Urocidin 62 Teriflunomide 62 TBC# 62 Aclidinium 62 Vertex hepatitis C 62 Study Evaluating 62 Quinamed 62 oral dihydropyrimidine dehydrogenase DPD 62 Evoltra 62 NDA Submission 62 Ranolazine 62 Atrasentan 62 STRIDE PD 62 Photocure 62 Genaera Corporation 62 severe hypercholesterolemia 62 Trabectedin 62 Receives Orphan Drug Designation 62 MedPulser 62 autologous cellular immunotherapy 62 generation purine nucleoside 62 Nexavar sorafenib tablets 62 Alemtuzumab 62 cediranib 62 relapsed leukemia 62 phase IIb trial 62 Gabapentin GR 62 Noxafil 62 Elan NanoCrystal 62 brivanib 62 vinca alkaloid 62 Cintredekin Besudotox 62 Inhalation Solution 62 pseudobulbar affect PBA 62 Therapeutic Competitors Report 62 Theratope 62 Therapeutic Competitors Companies 62 albiglutide 62 DAVANAT 62 Emisphere Technologies 62 rHuPH# recombinant human 62 refractory cutaneous T 62 Orathecin 62 Fresenius Biotech 62 Myozyme alglucosidase alfa 62 Initiated Phase 62 candidate epratuzumab 62 sodium glucose cotransporter 62 Initiate Phase II 62 HepeX B TM 62 regorafenib 62 VALOR trial 62 Fabry Disease 62 Carfilzomib 62 Tibotec Pharmaceuticals Ltd. 62 hyaluronidase enzyme 62 QUADRAMET R 62 Adamis Pharmaceuticals 62 luteinizing hormone releasing 62 Gelclair 62 Dabigatran etexilate 62 Advanced Melanoma 62 VISICOL R 62 alemtuzumab Campath 62 See CLINICAL PHARMACOLOGY 62 G#DT 62 Multiple Ascending Dose 62 UVIDEM 62 deforolimus 62 Tarmogen 62 Urocidin TM 62 FUSILEV ® 62 Æterna Zentaris 62 Sunesis Pharmaceuticals 62 samalizumab 62 Pegintron 62 Luteinizing Hormone Releasing Hormone 62 biliary tract cancer 62 ADVANCE PD 62 Dementia Related Psychosis 62 oxybutynin ATD TM 62 iobenguane 62 ZK EPO 62 Trandolapril 62 Therapeutic Competitors companiesandmarkets.com adEgemonye 62 ADVEXIN p# therapy 62 Phenoptin 62 targeting CD# 62 NeuVax 62 ATG Fresenius S 62 hormone LHRH antagonist 62 Investigational Treatment 62 successfully commercialize Iluvien 62 ATPace TM 62 stable nucleic acid 62 midstage clinical trials 62 Expression Genetics 62 Anticalin R 62 Pivotal Trial 62 Eltrombopag 62 Submits NDA 62 metaglidasen 62 KRN# 62 ViroChem Pharma Inc. 62 PDL# 62 Risperidone Oral Solution 62 Onalta 62 bevacizumab Avastin 62 Gemzar gemcitabine 62 sodium thiosulfate STS 62 Ichor Medical Systems 62 Rapaflo 62 TRISENOX 62 hypereosinophilic syndrome 62 Ticagrelor 62 Entest BioMedical 62 Tesamorelin 62 OvaRex 62 oral dual endothelin 62 Zevalin R Ibritumomab 62 rxRNA 61 Cimzia certolizumab pegol 61 IR BioSciences Holdings 61 pan HDAC inhibitor 61 Romidepsin 61 herpetic keratitis 61 sitaxsentan 61 EP #R 61 Drug Candidate 61 Matrix Phase 2b 61 ATL# [002] 61 Alogliptin 61 eligen 61 triphendiol 61 RNAi Therapeutic 61 LymphoStat B TM 61 5 fluorouracil leucovorin 61 Orphan Drug status 61 Phase IIIb 61 compound PMX # 61 Monoclonal antibody 61 Phase 1b clinical trials 61 Clofarabine 61 RTP #i 61 ADVEXIN 61 Increlex TM 61 Oncaspar 61 StromaCel Inc. 61 Kosan Biosciences Incorporated 61 Randomized Phase 61 NexACT ® 61 Onyx Pharmaceuticals Announces 61 INTEGRILIN R eptifibatide Injection 61 Thiarabine 61 supplemental biologics 61 Omalizumab 61 Hormone Refractory Prostate Cancer 61 telaprevir VX 61 Fortigel 61 casopitant 61 Proxinium 61 Phase III TRIST 61 acadesine 61 Onalta TM 61 aflibercept 61 Scancell 61 BrachySil TM 61 Second Pivotal Phase 61 IRESSA 61 vorinostat 61 sapacitabine CYC# 61 selective androgen receptor modulator 61 Revlimid lenalidomide 61 non peptidic protease 61 metastatic hormone refractory 61 PREOS R 61 ATL# [001] 61 phase Ib 61 Eniluracil 61 Sunshine Biopharma 61 Aliskiren 61 receptor tyrosine kinase inhibitor 61 vemurafenib 61 EndoTAG TM -1 61 Enhanze 61 Jevtana 61 Androxal TM 61 Accelerated Approval 61 tasocitinib 61 Valera Pharmaceuticals 61 vascular disrupting agent 61 ProMune 61 pharmacokinetic PK study 61 SUMAVEL 61 Receives Fast Track 61 IAP inhibitor 61 Saquinavir 61 Abiraterone acetate 61 elotuzumab 61 Rilonacept 61 Bellicum 61 evaluating picoplatin 61 FIRMAGON R 61 Reverset 61 Ataluren 61 neratinib 61 IMiD 61 PRIALT 61 Achieves Primary Endpoint 61 ocrelizumab 61 Enzyme Replacement Therapy 61 ATL/TV# 61 nephropathic cystinosis 61 Fentanyl TAIFUN R 61 topically applied SEPA 61 Uricase PEG 61 novel VDA molecule 61 Wellstat 61 Systemic Delivery 61 Arimoclomol 61 arsenic trioxide injection 61 Targretin 61 Corlux 61 Synerx Pharma 61 hypoxia activated prodrug 61 Therapy Evaluation 61 LEVADEX ™ 61 NM# [003] 61 PEP# [003] 61 Anticancer Drug 61 small molecule Hedgehog 61 Anturol ® 61 oral beclomethasone dipropionate 61 DNA intercalator 61 refractory gout 61 Intravitreal 61 Posaconazole 61 Commence Phase 61 FavId 61 Lenalidomide 61 Rheumatoid Arthritis Drug 61 Moxifloxacin 61 Granulocyte Colony Stimulating Factor 61 pertuzumab 61 Levoleucovorin 61 Amorcyte 61 huC# DM4 61 lenalidomide Revlimid 61 Rebif ® 61 Certolizumab pegol 61 Investigational Oral 61 Telatinib 61 ELND# 61 topically administered 61 Horizant 61 Sudhir Agrawal D.Phil 61 Phase 1b Clinical Trial 61 Irinotecan 61 Therapeutic Vaccine 61 Schizophrenia Treatment 61 DAVANAT R 61 REMINYL ® 61 Kinase Inhibitor 61 ONCASPAR 61 overactive bladder AA# 61 Auxilium Pharma 61 ASA# 61 Dynogen 61 mTOR inhibitor 61 Tocilizumab 61 Teikoku Pharma USA 61 Fenretinide 61 Asentar 61 NV1FGF 61 CancerVax Corporation 61 randomized Phase IIb 61 diagnostic radiopharmaceutical 61 including eniluracil ADH 61 sirtuin modulators 61 romidepsin 61 Golimumab 61 INTEGRILIN 61 Oral Spray 61 Calcitonin 61 Everolimus 61 ularitide 61 Nabi HB Intravenous 61 MGd 61 Genz # 61 Pancreate 61 Gastrotech 61 Traficet EN 61 Clevudine 61 NewLink 61 Firazyr 61 Agonist MABA program 61 Urokinase 61 BENLYSTA TM 61 Amyvid 61 Cethromycin 61 cromolyn sodium 61 investigational monoclonal antibody